MajesTEC-7

A Study to Compare Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) in Participants With Newly Diagnosed Multiple Myeloma (MajesTEC-7)

Near Add Your Location

Sorting 72 by

Memorial Sloan Kettering Cancer Center
New York, NY
  • Accepting patients
  • Show Principal Investigator
Fort Belvoir Community Hospital
Fort Belvoir, VA
  • Accepting patients
Ohio State University Comprehensive Cancer Center
James Cancer Hospital and Solove Research Institute
Columbus, OH
  • Accepting patients
City of Hope - Atlanta
Southeastern Regional Medical Center
Newnan, GA
  • Accepting patients
Ochsner LSU Health Shreveport
Ochsner Louisiana State University
Shreveport, LA
  • Not yet accepting
MD Anderson Cancer Center at Cooper
Cooper University Hospital
Camden, NJ
  • Not yet accepting
Georgetown Lombardi Comprehensive Cancer Center
MedStar Georgetown University Hospital
Washington, DC
  • Not yet accepting
Utah Cancer Specialists Cancer Center
Salt Lake City, UT
  • Accepting patients
Boston Medical Center
Boston, MA
  • Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.